Harnessing components of the immune system in bioengineered 3D tumor models
Immuno-Oncology Insights 2022; 3(8), 373–377
DOI: 10.18609/ioi.2022.040
Published: 8 September 2022
Viewpoint
Aleksander Skardal
“...in our in vitro/ex vivo bioengineered 3D tumor model systems, we have new technologies that could make significant differences in the quality of clinical care in the coming years, and as soon as now.”
